What’s Next After “Right to Try”?

What’s Next After “Right to Try”? What's Next After "Right to Try"?

Rising Development Costs Are Causing Drug Companies to Abandon Antibiotic Research

Rising Development Costs Are Causing Drug Companies to Abandon Antibiotic Research Rising Development Costs Are Causing Drug Companies to Abandon Antibiotic Research

Mr. President, You Can Slash Drug Prices Virtually Overnight Without Destroying Life-Saving Innovation

Mr. President, You Can Slash Drug Prices Virtually Overnight Without Destroying Life-Saving Innovation Mr. President, You Can Slash Drug Prices Virtually Overnight Without Destroying Life-Saving Innovation

Blog

What’s Next After “Right to Try”?

  The Right to Try bill, which gives terminally ill patients quicker access to new medicines, passed Congress earlier this year.  The Goldwater Institute initially promoted the passage of this bill state-by-state. Over 40 states passed Right to Try before it before it was signed into federal … [Read More...]

Rising Development Costs Are Causing Drug Companies to Abandon Antibiotic Research

This week, Novartis announced that it would be ending its research program designed to discover new antibiotics. The announcement was greeted with great concern, as “superbugs” resistant to our current arsenal of antibiotics, are a growing threat. In the early 1900s, infection was the primary … [Read More...]

Mr. President, You Can Slash Drug Prices Virtually Overnight Without Destroying Life-Saving Innovation

On July 9, President Trump lashed out at Pfizer for increasing prices of 41 drugs and lowering prices for 5. According to a Trump tweet, “Pfizer and others should be ashamed that they have raised drugs prices for no reason. They are merely taking advantage of the poor… We will respond!” Just a … [Read More...]

More from Dr. Ruwart's blog...